Friends of Leronlimab

Friends of Leronlimab
A New Therapeutic Drug for Covid #Leronlimab

☰

Recent News From CytoDyn


View	CytoDyn to Hold Webcast and Live Q/A on October 26
View	CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from Taking Place
View	CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
View	Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid
View	CytoDyn to Present at Emerging Growth Conference on October 13 Followed by Live Q/A
View	CytoDyn Announces Study to Evaluate Potential Synergistic Effects of Leronlimab with Immune Checkpoint Blockade (ICB)
View	CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s, While Nitya Ray, Ph.D. is Named CytoDyn’s New COO to Lead CMC and Regulatory Operations Specifically the BLA for HIV
View	CytoDyn Announces Legal Actions Against its Former CRO, Amarex Clinical Research
View	CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan”
View	CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A

This is a private website & not associated with CYDY, Leronlimab, Vyrologix, CytoDyn or cytodyn.com All names, images & website links are the property of their respective owners.


Home	Menu


Privacy	Term of Service